FDA Discloses FY 2016 Drug User Fee Rates
This article was originally published in Scrip
Executive Summary
The FDA on August 3 published the rates for fiscal year 2016 for user fees the agency intends to collect from makers of pharmaceuticals, biosimilars and generics and from firms considered pharmacy compounding outsourcing facilities.